High mobility group box-1 protein as a therapeutic target in perinatal hypoxic-ischemic brain injury
Kazuki Hatayama
Barbara S.Stonestreet
1.Department of Pediatrics,Women &Infants hospital of Rhode Island,The Alpert Medical School of Brown University,Providence,RI,USA2.Department of Pediatrics,Women &Infants hospital of Rhode Island,The Alpert Medical School of Brown University,Providence,RI,USA
摘要:Perinatal hypoxic-ischemic (HI) brain injury is a leading cause of morbidity and long-standing disability in newborns (Millar et al., 2017). Improved neonatal intensive care has increased survival in infants with pregnancy and birth related complications. Nonetheless, many surviving neonates exhibit neurological abnormalities that can persist throughout life (Millar et al., 2017). Early neuroprotective strategies have the potential to improve neurological outcomes and attenuate developmental delay in neonates.
机标关键词:
论文发表日期:2021-10-28
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
页数:2( 2006-2007 )
中国神经再生研究(英文版)

中国神经再生研究(英文版)

CSTPCDSCI
ISSN:1673-5374
年,卷(期):2021,16(10)
所属栏目:Perspectives